by palligoelme@gmail.com | May 28, 2026 | Clinical Trials
Conditions: Multiple Myeloma in Relapse; Multiple Myeloma, Refractory Interventions: Biological: Administration of CAR T-cells at 3 different dose levels Sponsors: Kure Cells, INC; CellServe LLC; Roya Clinical Not yet recruiting Conditions: Multiple Myeloma in...
by palligoelme@gmail.com | May 28, 2026 | Clinical Trials
Conditions: Multiple Mieloma; First Relpase; Rd-base Triplet Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Completed Conditions: Multiple Mieloma; First Relpase; Rd-base Triplet Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia...
by palligoelme@gmail.com | May 28, 2026 | Clinical Trials
Conditions: Fecal Incontinence Interventions: Device: Home-based anal electrical stimulator Sponsors: University Hospital, Martin; Comenius University Recruiting Conditions: Fecal Incontinence Interventions: Device: Home-based anal electrical stimulator Sponsors:...
by palligoelme@gmail.com | May 28, 2026 | Clinical Trials
Conditions: Periodontal Disease; Diabete Mellitus Interventions: Other: Questionnaire Survey Sponsors: University of Roma La Sapienza Recruiting Conditions: Periodontal Disease; Diabete Mellitus Interventions: Other: Questionnaire Survey Sponsors: University of Roma...
by palligoelme@gmail.com | May 27, 2026 | Clinical Trials
Conditions: Gastroesophageal Junction Adenocarcinoma Interventions: Drug: Tislelizumab; Drug: SKB315 for injection; Drug: Capecitabine Sponsors: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Not yet recruiting Conditions: Gastroesophageal Junction Adenocarcinoma...
by palligoelme@gmail.com | May 27, 2026 | Clinical Trials
Conditions: Evaluating Endoscopist Tip Control During STSC Application Interventions: Procedure: Ham-based Assessment Model Sponsors: University Hospital, Ghent Recruiting Conditions: Evaluating Endoscopist Tip Control During STSC Application Interventions:...